Peregrine Pharmaceuticals shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Peregrine Pharmaceuticals by Balyasny Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $1.3M | 112k | 11.38 |
2024-06-30 | $241k | 34k | 7.14 |
2023-09-30 | $265k | 28k | 9.44 |
2023-06-30 | $2.7M | 193k | 13.97 |
2021-03-31 | $1.4M | 77k | 18.24 |
2020-12-31 | $2.9M | 250k | 11.54 |